tiprankstipranks
Trending News
More News >
Abbvie (DE:4AB)
:4AB
Germany Market
Advertisement

AbbVie (4AB) Technical Analysis

Compare
23 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Abbvie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is 1.23, suggesting Abbvie is a Sell.
Abbvie’s (4AB) 20-Day exponential moving average is 163.12, while Abbvie’s (4AB) share price is €170, making it a Buy.
Abbvie’s (4AB) 50-Day exponential moving average is 163.07, while Abbvie’s (4AB) share price is €170, making it a Buy.

AbbVie (4AB) Pivot Points

Aug 01, 2025, 07:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
162.67
163.93
165.07
166.33
167.47
168.73
169.87
Fibonacci
163.93
164.85
165.42
166.33
167.25
167.82
168.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Aug 01, 2025, 07:12 PM
Period
Simple
Exponential
MA5
165.32Buy
166.18Buy
MA10
163.24Buy
164.43Buy
MA20
162.59Buy
163.12Buy
MA50
162.06Buy
163.07Buy
MA100
166.50Buy
165.37Buy
MA200
169.23Buy
167.37Buy
Abbvie’s (4AB) 10-Day exponential moving average is 164.43, while Abbvie’s (4AB) share price is €170, making it a Buy.
Abbvie’s (4AB) 100-Day exponential moving average is 165.37, while Abbvie’s (4AB) share price is €170, making it a Buy.
Abbvie’s (4AB) stock price is €170 and Abbvie’s (4AB) 50-day simple moving average is 162.06, creating a Buy signal.
Abbvie’s (4AB) stock price is €170 and Abbvie’s (4AB) 100-day simple moving average is 166.50, creating a Buy signal.
Abbvie’s (4AB) stock price is €170 and Abbvie’s (4AB) 200-day simple moving average is 169.23, creating a Buy signal.

AbbVie (4AB) Technical Indicators

Aug 01, 2025, 07:12 PM
Name
Value
Implied Action
RSI (14)
64.74
Neutral
STOCH (9,6)
86.88
Sell
STOCHRSI (14)
80.78
Sell
MACD (12,26)
1.23
Sell
ADX (14)
14.06
Buy
Williams %R
-20.00
Sell
CCI (14)
233.85
Sell
ATR (14)
3.11
-
Ultimate Oscillator
55.96
Neutral
ROC
4.31
Buy
Abbvie’s (4AB) Relative Strength Index (RSI) is 64.74, creating a Neutral signal.
Abbvie’s (4AB) Trend Strength Indicator (ADX) is 14.06, creating a Buy signal.
Abbvie’s (4AB) Commodity Channel Index (CCI) is 233.85, creating a Sell signal.
Abbvie’s (4AB) Price Rate of Change (ROC) is 4.31, creating a Buy signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Buy.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 64.74, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is 1.23, which suggests 4AB is a Sell.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 165.32, which suggests 4AB is a Buy.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 162.59, which suggests 4AB is a Buy.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 162.06, which suggests 4AB is a Buy.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 169.23, which suggests 4AB is a Buy.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -20.00, which suggests 4AB is a Sell.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is 233.85, which suggests 4AB is a Sell.
                    What is the share price of Abbvie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis